Impact of Prehabilitation and Comprehensive Follow-up in Women With Breast Cancer

Recruiting N/A Interventional Study
Breast Cancer Breast Neoplasms
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Female
Study type
Interventional
Purpose
Supportive Care
Participants needed
66 (estimated)
Sponsor
European University Miguel de Cervantes · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Breast cancer (BC) is the most common cancer among women worldwide. Cancer treatments are associated with numerous adverse events that reduce patients' functionality and alter their clinical and molecular profiles. Physical exercise and adherence to nutritional guidelines during treatment and survivorship have been shown to improve recovery prognosis and reduce treatment-related complications. How…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Women who have a newly confirmed diagnosis of stage 0-III breast cancer. * Age 18 to 65 years old with a body mass index between 18.5 and 35 kg·m-². * Have a medical indication for surgery or neoadjuvant systemic treatment (chemotherapy or hormone therapy) or radiotherapy. * B…
Contacts

Alejandro Santos Lozano, PhD

+34 983001000

asantos@uemc.es

CONTACT

Celia García Chico, PhD

+34 983001000

cgarciac@uemc.es

CONTACT